NCT05746923 Lesser Poland Cracovian Heart Failure Registry
| NCT ID | NCT05746923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2023-02-15 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2023-02-15 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) is to expand the knowledge about acute heart failure (AHF) and its long-term prognosis. The main questions are: * assessment of long-term prognosis of AHF and its determinants * determination of the optimal AHF treatment methods * assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects * analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)
Eligibility Criteria
Inclusion Criteria: * hospitalization due to acute heart failure * \> 18 years of age Exclusion Criteria: * inability to give informed consent to participate in the registry
Contact & Investigator
Jadwiga Nessler, Prof.
STUDY CHAIR
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow
Frequently Asked Questions
Who can join the NCT05746923 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05746923 currently recruiting?
Yes, NCT05746923 is actively recruiting participants. Contact the research team at konrad.stepien@uj.edu.pl for enrollment information.
Where is the NCT05746923 trial being conducted?
This trial is being conducted at Krakow, Poland.
Who is sponsoring the NCT05746923 clinical trial?
NCT05746923 is sponsored by Jagiellonian University. The principal investigator is Jadwiga Nessler, Prof. at Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.